High Glucose Induces Dysfunction and Apoptosis in Endothelial Cells: Is the Effect of High Glucose Persistence more Important than Concentration?

Abstract

Oxidative stress and inflammation are involved in the pathogenesis of diabetic endothelial dysfunction. Herein we reported the biological changes induced by hyperglycemia in human umbilical vein endothelial cells (HUVECs) and the potential underlying mechanisms sought to determine whether high glucose concentration or the persistence plays a key role in the development of vascular lesions. The HUVECs were exposed to various glucose concentrations (5, 15, 30, and 60 mmol/L of D-glucose supplemented), and several oxidative stress factors, such as NO, NOS, and ROS, and inflammatory signaling markers, such as TNF-α, TNFR, RIP, TRADD, TRAF-2 and NF-κB, were analyzed at various times (24, 48, 72, and 96 h). High glucose (HG) induced a transient increase of NO within 24 h and decreased afterwards, in accord with the expression of eNOS. HG also increased ROS and TNF-α production and activated the TNF-α-mediated signal transduction, decreasing cell viability and inducing apoptosis. However, 3 HG groups had similar effects on HUVECs with the increased duration of exposure, which resulted in the amplified oxidative and inflammatory damage. Taken together, these findings suggest that the HG persistence exacerbates oxidative stress and activates the inflammatory-mediated signaling pathways, inducing endothelial dysfunction and apoptosis, regardless of the concentration of HG. Our results provide the first evidence that HG persistence is more important than concentration in the progress of diabetic endothelial dysfunction.

high glucose - endothelial cell - persistence - concentration

References

• 1 Adler AI, Stevens RJ, Neil A. et al . UKPDS 59: Hyperglycemia and Other Potentially Modifiable Risk Factors for Peripheral Vascular Disease in Type 2 Diabetes.  Diabetes Care. 2002;  25 894-899
• 2 Bagi Z, Toth E, Koller A. et al . Microvascular dysfunction after transient high glucose is caused by superoxide-dependent reduction in the bioavailability of NO and BH (4).  Am J Physiol Heart Circ Physiol. 2004;  287 (2) H626-H633
• 3 Blagosklonny MV. Aging: ROS or TOR.  Cell Cycle. 2008;  7 (21) 3344-3354
• 4 Brodsky SV, Gao S, Li H. et al . Hyperglycemic switch from mitochondrial nitric oxide to superoxide production in endothelial cells.  Am J Physiol Heart Circ Physiol. 2002;  283 (5) H2130-H2139
• 5 BrownLee M. Biochemistry and molecular cell biology of diabetic complications.  Nature. 2001;  414 813-820
• 6 Busik JV, Mohr S, Grant MB. Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators.  Diabetes. 2008;  57 (7) 1952-1965
• 7 Cohen G, Riahi Y, Alpert E. et al . The roles of hyperglycaemia and oxidative stress in the rise and collapse of the natural protective mechanism against vascular endothelial cell dysfunction in diabetes.  Arch Physiol Biochem. 2007;  113 (4-5) 259-267
• 8 Cooke CL, Davidge ST. Peroxynitrite increases iNOS through NF-kappaB and decreases prostacyclin synthase in endothelial cells.  Am J Physiol Cell Physiol. 2002;  282 (2) C395-C402
• 9 Esberg LB, Ren J. Role of nitric oxide, tetrahydrobiopterin and peroxynitrite in glucose toxicity-associated contractile dysfunction in ventricular myocytes.  Diabetologia. 2003;  46 (10) 1419-1427
• 10 Gao L, Mann GE. Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signaling.  Cardiovasc Res. 2009;  82 (1) 9-20
• 11 Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications.  Diabetes Care. 1996;  19 257-267
• 12 Gregg EW, Gu Q, Cheng YJ. et al . Mortality trends in men and women with diabetes, 1971–2000.  Ann Intern Med. 2007;  147 (3) 149-155
• 13 Hanssen KF. Blood glucose control and microvascular and macrovascular complications in diabetes.  Diabetes. 1997;  46 (S 02) S101-S103
• 14 Hayashi T, Matsui-Hirai H, Miyazaki-Akita A. et al . Endothelial cellular senescence is inhibited by nitric oxide: implications in atherosclerosis associated with menopause and diabetes.  Proc Natl Acad Sci USA. 2006;  103 (45) 17018-17023
• 15 Higgins GT, Khan J, Pearce IA. Glycaemic control and control of risk factors in diabetes patients in an ophthalmology clinic: what lessons have we learned from the UKPDS and DCCT studies?.  Acta Ophthalmol Scand. 2007;  85 (7) 772-776
• 16 Ho FM, Liu SH, Liau CS. et al . High glucose induced apoptosis in human endothelial cells is mediated by sequential activations of c-Jun NH(2)-terminal kinase and caspase-3.  Circulation. 2000;  101 2618-2624
• 17 Hoshiyama M, Li B, Yao J. et al . Effect of high glucose on nitric oxide production and endothelial nitric oxide synthase protein expression in human glomerular endothelial cells.  Nephron Exp Nephrol. 2003;  95 (2) e62-e68
• 18 Hunter I, Nixon GF. Spatial compartmentalization of tumor necrosis factor (TNF) receptor 1-dependent signaling pathways in human airway smooth muscle cells. Lipid rafts are essential for TNF-alpha-mediated activation of RhoA but dispensable for the activation of the NF-kappaB and MAPK pathways.  J Biol Chem. 2006;  281 (45) 34705-34715
• 19 Hur GM, Lewis J, Yang Q. et al . The death domain kinase RIP has an essential role in DNA damage-induced NF-kappa B activation.  Genes Dev. 2003;  17 (7) 873-882
• 20 Inoguchi T, Li P, Umeda F. et al . High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells.  Diabetes. 2000;  49 (11) 1939-1945
• 21 Joussen AM, Doehmen S, Le ML. et al . TNF-alpha mediated apoptosis plays an important role in the development of early diabetic retinopathy and long-term histopathological alterations.  Mol Vis. 2009;  15 1418-1428
• 22 Kern TS. Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy.  Exp Diabetes Res. 2007;  2007 95103
• 23 Lee CI, Liu X, Zweier JL. Regulation of xanthine oxidative by nitric oxide and peroxynitrite.  J Biol Chem. 2000;  275 9369-9376
• 24 Lindström J, Uusitupa M. Lifestyle intervention, diabetes, and cardiovascular disease.  Lancet. 2008;  371 (9626) 1731-1733
• 25 Liu ZG. Molecular mechanism of TNF signaling and beyond.  Cell Res. 2005;  15 (1) 24-27
• 26 Lundberg JO, Weitzberg E. NO generation from nitrite and its role in vascular control.  Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;  25 (5) 915-922
• 27 Madamanchi NR, Runge MS. Mitochondrial dysfunction in atherosclerosis.  Circ Res. 2007;  100 (4) 460-473
• 28 Nakagami H, Kaneda Y, Ogihara T. et al . Endothelial dysfunction in hyperglycemia as a trigger of atherosclerosis.  Curr Diabetes Rev. 2005;  1 (1) 59-63
• 29 Newsholme P, Haber EP, Hirabara SM. et al . Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity.  J Physiol. 2007 Aug 15;  583 (Pt 1) 9-24
• 30 Okuda Y, Kawashima K, Suzuki S. et al . Restoration of nitric oxide production by aldose reductase inhibitor in human endothelial cells cultured in high-glucose medium.  Life Sci. 1997;  60 (3) PL53-PL56
• 31 Oliveira HC, Cosso RG, Alberici LC. et al . Oxidative stress in atherosclerosis-prone mouse is due to low antioxidant capacity of mitochondria.  FASEB J. 2005;  19 (2) 278-280
• 32 Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease.  Physiol Rev. 2007;  87 (1) 315-424
• 33 Piconi L, Corgnali M, Da Ros R. et al . The protective effect of rosuvastatin in human umbilical endothelial cells exposed to constant or intermittent high glucose.  J Diabetes Complications. 2008;  22 (1) 38-45
• 34 Quagliaro L, Piconi L, Assaloni R. et al . Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin expression in human umbilical vein endothelial cells in culture: the distinct role of protein kinase C and mitochondrial superoxide production.  Atherosclerosis. 2005;  183 (2) 259-267
• 35 Rajesh M, Mukhopadhyay P, Bátkai S. et al . Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption.  Am J Physiol Heart Circ Physiol. 2007;  293 (1) H610-H619
• 36 Raskin P, Rosenstock J. Blood glucose control and diabetic complications.  Ann Intern Med. 1986;  105 (2) 254-263
• 37 Sheikh MS, Huang Y. Death receptor activation complexes: it takes 2 to activate TNF receptor 1.  Cell Cycle. 2003;  2 (6) 550-552
• 38 Srinivasan S, Hatley ME, Bolick DT. et al . Hyperglycaemia-induced superoxide production decreases eNOS expression via AP-1 activation in aortic endothelial cells.  Diabetologia. 2004;  47 (10) 1727-1734
• 39 Xiao-Yun X, Zhuo-Xiong C, Min-Xiang L. et al . Ceramide mediates inhibition of the AKT/eNOS signaling pathway by palmitate in human vascular endothelial cells.  Med Sci Monit. 2009;  15 (9) BR254-BR261
• 40 Xu HQ, Hao HP, Zhang X. et al . Morroniside protects cultured human umbilical vein endothelial cells from damage by high ambient glucose.  Acta Pharmacol Sin. 2004;  25 (4) 412-415
• 41 Yang Z, Mo X, Gong Q. et al . Critical effect of VEGF in the process of endothelial cell apoptosis induced by high glucose.  Apoptosis. 2008;  13 (11) 1331-1343

Correspondence